Ex vivo alendronate localization at the mesoporous titania implant/bone interface

  • Johan Karlsson
  • Necati Harmankaya
  • Stefan Allard
  • Anders Palmquist
  • Mats Halvarsson
  • Pentti Tengvall
  • Martin Andersson
Biocompatibility Studies
Part of the following topical collections:
  1. Biocompatibility Studies


An attractive approach in implant technology is local drug delivery, and design of efficient, safe and reliable treatments. Our hitherto strategy has been to coat Ti implants with a thin mesoporous TiO2 film that in turn is loaded with an osteoporosis drug, such as Alendronate (ALN) that is known to suppress osteoclastic activity. This system has proven highly successful and results in excellent osseointegration. However, more detailed information about drug-release and distribution at the bone/implant interface is needed. In this study, 14C-ALN loaded titanium implants were placed up to 8 weeks into rat tibia and the spatial–temporal distribution of the drug was evaluated. Autoradiography data demonstrated a sustained release of 14C-ALN and the released drug remained bound to bone in close vicinity, within 500 micrometers, of the implants. Liquid scintillation counting experiments confirmed that the distal transport of released 14C-ALN was extremely low. The results are favorable as they show that ALN stays for a long time in the vicinity of the implant and may therefore improve for a long time the mechanical fixation of bone anchored implants. Moreover, these findings suggest due to the low systemic spreading a minimal risk of Alendronate related systemic side effects.


Alendronate Mesoporous TiO2 Mesoporous Titania Osteoporosis Drug Autoradiographic Image 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We gratefully thank the Materials Area of Advance at Chalmers University of Technology and University of Gothenburg, BIOMATCELL VINN Excellence Center for Biomaterials and Cell Therapy, Hjalmar Svensson foundation, and the Swedish Research Council, VR (K2012-52X-09495-25-3, 621-2011-6037) for their financial support. A grant from Knut and Alice Wallenberg Foundation for the acquiring of the FEG-SEM instrument is gratefully acknowledged.


  1. 1.
    Pilliar RM. Modern metal processing for improved load-bearing surgical implants. Biomaterials. 1991;12:95–100.CrossRefGoogle Scholar
  2. 2.
    Rouleau DM, Sandman E, van Riet R, Galatz LM. Management of fractures of the proximal ulna. J Am Acad Orthop Surg. 2013;21:149–60.Google Scholar
  3. 3.
    Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog. 2009;25:1539–60.Google Scholar
  4. 4.
    Dash AK, Cudworth GC. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods. 1998;40:1–12.CrossRefGoogle Scholar
  5. 5.
    Colilla M, Manzano M, Vallet-Regi M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomedicine. 2008;3:403–14.Google Scholar
  6. 6.
    Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed. 2007;46:7548–58.CrossRefGoogle Scholar
  7. 7.
    Zhao L, Mei S, Chu PK, Zhang Y, Wu Z. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials. 2010;31:5072–82.CrossRefGoogle Scholar
  8. 8.
    Chen F-M, Wu L-A, Zhang M, Zhang R, Sun H-H. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives. Biomaterials. 2011;32:3189–209.CrossRefGoogle Scholar
  9. 9.
    Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone. 1996;18:75–85.CrossRefGoogle Scholar
  10. 10.
    Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res. 2007;86:1022–33.CrossRefGoogle Scholar
  11. 11.
    Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19:733–59.CrossRefGoogle Scholar
  12. 12.
    Giger EV, Castagner B, Leroux J-C. Biomedical applications of bisphosphonates. J Control Release. 2013;167:175–88.CrossRefGoogle Scholar
  13. 13.
    Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone. 2008;42:365–71.CrossRefGoogle Scholar
  14. 14.
    Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials. 2004;25:2133–8.CrossRefGoogle Scholar
  15. 15.
    Abtahi J, Tengvall P, Aspenberg P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone. 2012;50:1148–51.CrossRefGoogle Scholar
  16. 16.
    Harmankaya N, Karlsson J, Palmquist A, Halvarsson M, Igawa K, Andersson M, et al. Raloxifene and alendronate containing thin mesoporous titanium oxide films improve implant fixation to bone. Acta Biomater. 2013;9:7064–73.CrossRefGoogle Scholar
  17. 17.
    Grosso D, Cagnol F, Soler-Illia G, Crepaldi EL, Amenitsch H, Brunet-Bruneau A, et al. Fundamentals of mesostructuring through evaporation-induced self-assembly. Adv Funct Mater. 2004;14:309–22.CrossRefGoogle Scholar
  18. 18.
    Alberius PCA, Frindell KL, Hayward RC, Kramer EJ, Stucky GD, Chmelka BF. General predictive syntheses of cubic, hexagonal, and lamellar silica and titania mesostructured thin films. Chem Mater. 2002;14:3284–94.CrossRefGoogle Scholar
  19. 19.
    Andersson M, Birkedal H, Franklin NR, Ostomel T, Boettcher S, Palmqvist AEC, et al. Ag/agcl-loaded ordered mesoporous anatase for photocatalysis. Chem Mater. 2005;17:1409–15.CrossRefGoogle Scholar
  20. 20.
    Jarmar T, Palmquist A, Brånemark R, Hermansson L, Engqvist H, Thomsen P. Technique for preparation and characterization in cross-section of oral titanium implant surfaces using focused ion beam and transmission electron microscopy. J Biomed Mater Res Part A. 2008;87A:1003–9.CrossRefGoogle Scholar
  21. 21.
    Wennerberg A, Jimbo R, Allard S, Skarnemark G, Andersson M. In vivo stability of hydroxyapatite nanoparticles coated on titanium implant surfaces. Int J Oral Maxillofac Implants. 2011;26:1161–6.Google Scholar
  22. 22.
    Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft-tissues—the sage-schliff (sawing and grinding) technique. J Oral Pathol Med. 1982;11:318–26.CrossRefGoogle Scholar
  23. 23.
    McKenzie K, Bobyn JD, Roberts J, Karabasz D, Tanzer M. Bisphosphonate remains highly localized after elution from porous implants. Clin Orthop Relat Res. 2011;469:514–22.CrossRefGoogle Scholar
  24. 24.
    Abtahi J, Agholme F, Sandberg O, Aspenberg P. Effect of local versus systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw. J Dent Res. 2013;92:279–83.CrossRefGoogle Scholar
  25. 25.
    Leite AF, Ogata FDS, de Melo NS, Figueiredo PTDS. Imaging findings of bisphosphonate-related osteonecrosis of the jaws: a critical review of the quantitative studies. Int J Dent. 2014;2014:784348.CrossRefGoogle Scholar
  26. 26.
    Fazil M, Baboota S, Sahni JK, Ameeduzzafar, Ali J. Bisphosphonates: therapeutics potential and recent advances in drug delivery. Drug Deliv. 2014.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Johan Karlsson
    • 1
  • Necati Harmankaya
    • 2
  • Stefan Allard
    • 3
  • Anders Palmquist
    • 2
  • Mats Halvarsson
    • 4
  • Pentti Tengvall
    • 2
  • Martin Andersson
    • 1
  1. 1.Department of Chemical and Biological Engineering, Applied ChemistryChalmers University of TechnologyGothenburgSweden
  2. 2.Department of BiomaterialsSahlgrenska Academy at University of GothenburgGothenburgSweden
  3. 3.Department of Chemical and Biological Engineering, Nuclear ChemistryChalmers University of TechnologyGothenburgSweden
  4. 4.Department of Applied Physics, Materials MicrostructureChalmers University of TechnologyGothenburgSweden

Personalised recommendations